Andover, MA, United States of America

Eileen Z Zhang

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eileen Z Zhang. Retrieved from https://idiyas.com/inventor/eileen-z-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eileen Z Zhang: Innovator in Hepatitis C Research

Introduction

Eileen Z Zhang is a prominent inventor based in Andover, MA (US). She has made significant contributions to the field of medical research, particularly in the area of hepatitis C virus (HCV) amplification. Her innovative methods have the potential to enhance diagnostic capabilities and improve patient outcomes.

Latest Patents

Eileen Z Zhang holds 1 patent for her work titled "Methods for amplifying hepatitis C virus nucleic acids." This patent describes a method of amplifying an HCV nucleic acid in an HCV infected sample. The process involves a two-stage PCR, utilizing specific primers to ensure accurate amplification of the viral genome.

Career Highlights

Eileen is currently employed at Vertex Pharmaceuticals, Inc., where she continues to advance her research in virology. Her work is crucial in developing effective treatments for hepatitis C, a virus that affects millions worldwide.

Collaborations

Eileen has collaborated with notable colleagues, including James Daniel Frantz and Tara Lynn Kieffer. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in the field.

Conclusion

Eileen Z Zhang's contributions to hepatitis C research exemplify the impact of innovation in medical science. Her work not only advances our understanding of the virus but also paves the way for improved diagnostic and therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…